FindTrial
Sign In

Detection of circulating tumor DNA by droplet digital PCR in patients with unresectable or recurrent gastric cancer

Detection of circulating tumor DNA by droplet digital PCR in patients with unresectable or recurrent gastric cancer - Detection of circulating tumor DNA in unresectable or recurrent gastric cancer patients

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000026605
Enrollment
20
Registered
2017-03-18
Start date
2017-03-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Detection of circulating tumor DNA by droplet digital PCR device

Sponsors

Second Department of Surger, Wakayama medical university, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Histologically confirmed carcinoma of the stomach. Diagnosed as unresectable gastric cancer or recurrent gastric cancer. Appropriate informed consent obtained

Exclusion criteria

Exclusion criteria: Patients who are diagnosed as in appropriate for the study

Design outcomes

Primary

MeasureTime frame
Investigation of detectability of circulating tumor DNA in patients with unresectable or reucrrent gastric cancer—

Secondary

MeasureTime frame
Investigation of relation between ciruculating tumor DNA status and sensitivity to anticancer agents. Investigation of relation between ciruculating tumor DNA status and prognosis—

Countries

Japan

Contacts

Public ContactToshiaki Tsuji

Wakayama medical university, School of Medicine Second Department of Surgery

totsuji@wakayama-med.ac.jp073-441-0613

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026